The study compound may potentially be used to treat parasitic infections in humans. It has been safely used for many years to treat parasitic worm infections in animals. Researchers are now studying the study compound to see if it can also help treat certain human parasitic infections.
This trial consists of two parts. You can only participate in one part.
In Part 1, you will first be given the radioactively labeled study compound once as a small drink. This will be slowly administered into your cheek pouch using a syringe without a needle. After this, you will drink some water.
In Part 2, you will first be given the study compound as a tablet by mouth with water. This is followed by a solution containing the radioactively labeled study compound given directly into a blood vessel.
In this trial we will investigate how quickly and to what extent the study compound is absorbed, transported, and eliminated from the body. To investigate this, the compound contains a small amount of a radioactive substance. The radioactivity disappears from the body at the same time as the compound through the feces, urine and/or breath. The compound has a radiation exposure lower than the natural background radiation that you are exposed to in the Netherlands in 1 month. This background radiation comes from space, soil, air, water, food and construction materials. To measure radioactivity levels in your body, blood, urine and feces (the last two only apply in Part 1) will be collected during the trial.